TLR4 and colorectal carcinoma: Anti-Gram-negative pathogenic bacteria [22,23,24], anti-inflammation, and anti-CRC cancer progression of these compounds has been revealed [21,25], However, their action on LPS-TLR4 of CRC has not been researched before.